Pharmacovigilance & Drug Safety Capability Pathway
Develop the scientific judgement, regulatory awareness, and safety reasoning required to support global medicine safety throughout the drug lifecycle.
Case processing • Signal evaluation • Risk management workflows • Industry simulation
Why Pharmacovigilance Is Central to Patient Safety
Pharmacovigilance is the global system responsible for detecting, assessing, and preventing adverse effects associated with medicines after and during development. Every safety report reviewed and every signal evaluated contributes to regulatory decisions that protect patients worldwide.
Pharmaceutical companies and regulatory authorities rely on trained safety professionals to interpret safety data, maintain compliance, and ensure that benefit–risk profiles remain continuously monitored throughout a product’s lifecycle.
Working in pharmacovigilance therefore requires structured reasoning, regulatory awareness, and the ability to operate within highly governed safety systems.
Where Pharmacovigilance Fits in the Drug Development Lifecycle
The development of a medicine does not end at regulatory approval. In fact, pharmacovigilance becomes even more critical once a medicine reaches the wider patient population.
Drug development typically progresses through several key stages:
- Discovery and Preclinical Research
- Clinical Trials
- Regulatory Review and Approval
- Post-Marketing Safety Monitoring
Pharmacovigilance activities extend across the entire lifecycle of a medicine, with a particular focus on post-authorisation safety monitoring.
During this phase, pharmacovigilance teams evaluate real-world safety data to ensure that emerging risks are identified and addressed quickly.
Pharmacovigilance Within the Global Regulatory System
Pharmacovigilance activities operate within a global regulatory framework designed to ensure that medicines remain safe throughout their lifecycle.
Regulatory authorities require pharmaceutical companies to maintain robust safety monitoring systems and to report adverse events in accordance with international guidelines.
Key regulatory frameworks that govern pharmacovigilance include:
- ICH E2 safety reporting guidelines
- European Union Good Pharmacovigilance Practices (GVP)
- UK MHRA pharmacovigilance regulations
- FDA post-marketing safety reporting requirements
These frameworks ensure that safety data is systematically collected, analysed and communicated across global regulatory networks.
Healthcare professionals trained through PharmaLink Academy now work across leading global pharmaceutical organisations
Our alumni have successfully transitioned into roles across pharmacovigilance, regulatory affairs, clinical development and medical writing within global pharmaceutical companies and CROs.
Systems and Tools Used in Pharmacovigilance
Pharmacovigilance professionals operate specialised safety systems used to manage and evaluate safety data.
These systems allow teams to collect adverse event reports, analyse safety trends and generate regulatory reports required by health authorities.
Common pharmacovigilance tools include:
- Safety databases such as Argus and ARISg
- MedDRA medical coding dictionaries
- Regulatory reporting systems for Individual Case Safety Reports
- Signal detection and safety analytics platforms
Within the PharmaLink Academy programme, students gain hands-on experience through our simulated safety database PharmaLink VIGILANT, designed to replicate the workflows used in pharmaceutical safety departments.
Who This Programme Is Designed For
This programme is designed for healthcare and life sciences professionals seeking to transition into the pharmaceutical industry.
Typical participants include:
- Pharmacists
- Biomedical scientists
- Nurses
- Medical graduates
- Clinical research professionals
- Life science graduates
Participants gain the regulatory awareness and operational understanding required to contribute to pharmacovigilance activities within the pharmaceutical industry.
Designed Around Real Drug Safety Workflows
The pathway mirrors how pharmacovigilance operates within pharmaceutical organisations. Participants engage with structured safety scenarios reflecting real industry processes, allowing familiarity with how safety data is reviewed, documented, and escalated within regulated environments.
Exposure includes:
• Simulated safety case handling
• Structured review and justification exercises
• Safety database reasoning
• Expert-led evaluation feedback
Professional Outcomes
Participants complete the pathway with:
Practical understanding of safety case workflows
Confidence interpreting adverse event information
Familiarity with regulatory safety expectations
Exposure to signal and risk evaluation thinking
Readiness to contribute within pharmacovigilance teams
Progressive Capability Levels
Each level builds progressively toward professional confidence within pharmacovigilance environments.
Tier 1
Foundations of safety operations and regulatory awareness establishing pharmacovigilance foundations.
Apply for the ProgrammeTier 2
Scientific evaluation, case assessment, and signal thinking.
Note: You must complete Tier 1 before progressing to Tier 2.
Apply for the ProgrammeEach level builds progressively toward professional confidence within pharmacovigilance environments.
Real-World Pharmacovigilance Activities You Will Perform
Pharmacovigilance is a highly analytical and documentation-driven discipline.
PharmaLink's pharmacovigilance pathway is structured to support the progressive development of safety capability within the pharmaceutical industry. Participants advance through two levels, moving from operational pharmacovigilance foundations to higher-level safety science and regulatory decision-making.
TIER 1 Pharmacovigilance Foundations
Duration: 8 Weeks
During the initial intensive phase, participants are guided through the foundations of regulatory medical writing and the structure of key clinical development documents. This phase includes:
- Case intake and ICSR processing
- MedDRA coding
- Adverse event narrative writing
- Regulatory reporting principles
- Pharmacovigilance documentation processes
- Introductory signal detection concepts
Participants complete structured case evaluation exercises designed to develop familiarity with adverse event assessment and safety documentation workflows.
TIER 2 Pharmacovigilance Scientist Development
Duration: 10 Weeks
This level builds on the operational foundations developed in Tier 1 and focuses on higher-level pharmacovigilance science and regulatory judgement. Participants develop capability in:
- Signal detection and validation
- Literature screening and safety signal identification
- Aggregate reporting including DSUR and PBRER
- Risk management plan development
- Pharmacovigilance CAPA and quality systems
- Regulatory inspection readiness
Participants also work with simulated safety database cases within PharmaLink VIGILANT, strengthening their ability to analyse safety data and apply pharmacovigilance reasoning in realistic safety scenarios.
Total Pharmacovigilance Capability Pathway
6 Months
Participants completing both levels progress through an approximately 6-month pharmacovigilance capability pathway, developing the operational and analytical skills required for pharmacovigilance roles within the pharmaceutical industry.
PharmaLink programmes are designed to support the development of pharmacovigilance capability aligned with industry practices used by pharmaceutical companies and contract research organisations.
Common Pharmacovigilance Career Pathway
Pharmacovigilance plays a critical role in monitoring the safety of medicines throughout their lifecycle. Pharmaceutical companies and contract research organisations rely on pharmacovigilance professionals to identify, evaluate and manage safety signals associated with medicinal products.
The pharmacovigilance capability pathway at PharmaLink supports healthcare professionals in developing the operational and analytical skills required for safety roles within the pharmaceutical industry.
TIER 1 Entry-Level Roles
Professionals who develop pharmacovigilance capability may progress into roles such as:
- Pharmacovigilance Associate
- Drug Safety Associate
- Safety Case Processor
- Pharmacovigilance Officer
These roles focus on the operational foundations of pharmacovigilance, including adverse event processing, narrative writing, and regulatory reporting.
Entry Level UK Salary: £25,000–£50,000
Apply for the ProgramTIER 2 Scientist-Level Roles
As experience develops, professionals may progress into more analytical roles such as:
- Pharmacovigilance Scientist
- Drug Safety Scientist
- Signal Detection Specialist
- Risk Management Specialist
These roles involve analysing safety trends, evaluating signals and contributing to regulatory safety reports such as DSURs and PBRERs.
Entry Level UK Salary: £35,000–£60,000
Apply for the ProgramIndustry Employers
Pharmacovigilance professionals work across a range of organisations including:
- Pharmaceutical companies
- Biotechnology companies
- Contract research organisations (CROs)
- Regulatory agencies
- Safety consulting firms
The PharmaLink Pharmacovigilance Capability Pathway is designed to help participants develop the foundational and analytical safety skills expected within these professional environments.
Next Cohorts
Evening classes run 6 to 8 pm. Intake is limited for quality mentorship and 1-1 feedback.
| Start Date | Enrollment Deadline | Intake Size | Format | Action |
|---|---|---|---|---|
| TBC | TBC | Up to 30 | Live evenings |
Apply Here |
Industry Insight: Why Pharmacovigilance Matters in Modern Medicine
Every medicine authorised for use continues to be monitored throughout its lifecycle. Even after approval, new safety information can emerge when medicines are used by larger and more diverse patient populations.
Pharmacovigilance is the scientific discipline responsible for identifying, assessing and preventing adverse effects associated with medicines. It plays a critical role in protecting public health and ensuring that the benefits of medicines continue to outweigh potential risks.
Regulatory agencies across the world, including the European Medicines Agency and the UK Medicines and Healthcare products Regulatory Agency, require pharmaceutical companies to maintain structured pharmacovigilance systems to monitor medicine safety after approval.
These activities are governed by internationally recognised regulatory frameworks such as Good Pharmacovigilance Practices (GVP), which define how safety data must be collected, evaluated and communicated.
At PharmaLink Academy, our pharmacovigilance training programmes are designed to reflect these real-world regulatory systems, preparing healthcare professionals to contribute meaningfully to global drug safety operations.
Read Industry Insight
Founder Authority
Designed under the leadership of Dorothy Ogwuru, former Global Head of Pharmacovigilance with extensive experience across pharmaceutical safety systems, regulatory compliance, and global drug safety operations.
This pathway reflects real-world pharmacovigilance expectations rather than theoretical instruction.
Experiences From PharmaLink Participants
Healthcare professionals from clinical and scientific backgrounds have developed regulatory and pharmacovigilance capability through PharmaLink programmes and progressed into pharmaceutical industry roles.
Explore how healthcare professionals are transitioning into pharmaceutical industry roles.
Explore Capability PathwaysStep Into Drug Safety With Structured Preparation
Pharmacovigilance requires analytical thinking, regulatory awareness, and professional judgement. This pathway provides the structured environment needed to begin that transition with confidence.
